- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Eris Lifesciences Limited — Important, 20-04-2026: Updates
20-04-2026 | 10:25 pm
20-04-2026 | 10:25 pm
Eris Lifesciences' Swiss Parenterals units faced HALMED observations on GMP compliance. While existing business sees minimal impact, expect delays in their EU-CDMO product pipeline. Remediation is underway.
No comments yet. Be the first to comment!